Know Cancer

or
forgot password

Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer


N/A
50 Years
75 Years
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer


EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic
outcomes.

Inclusion Criteria


- Persons 50-75

- Asymptomatic for lung cancer

- Current or former (stopped smoking less than 10 years ago) cigarette smokers

- History of cigarette smoking of at least 20 pack years

- History of cigarette smoking with a family history of lung cancer which gives an
individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5
years).

- Mentally competent individuals to sign an informed consent.

- Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.

- A fully informed signed consent form must have been obtained.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

David Midthun, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

10-003048

NCT ID:

NCT01203579

Start Date:

September 2011

Completion Date:

September 2011

Related Keywords:

  • Lung Cancer
  • CDT-Lung,CT scan,lung cancer detection
  • Lung Neoplasms

Name

Location

Mayo Clinic in RochesterRochester, Minnesota  55905